← MARAVAI LIFESCIENCES HOLDINGS, INC.
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Net loss | ($5.2m) | $78.8m | $469.2m | $490.7m | ($138.4m) | ($259.6m) | ($230.8m) | — | |
| Depreciation | $3.8m | $5.5m | $6.4m | $7.6m | $12.9m | $20.9m | $23.6m | $29.9m | |
| Amortization of intangible assets | $20.3m | $20.3m | $18.3m | $24.3m | $27.4m | $27.5m | $28.0m | — | |
| Amortization of operating lease right-of-use assets | $0 | $0 | $8.8m | $6.3m | $8.5m | $8.5m | $9.0m | — | |
| Amortization of deferred financing costs | $1.7m | $1.8m | $2.7m | $2.8m | $2.9m | $2.9m | $1.7m | — | |
| Deferred income taxes | ($1.2m) | ($5.5m) | $46.9m | $42.3m | $754.9m | $11k | ($20k) | ($20k) | |
| Stock-based compensation expense | $1.7m | $24.6m | $10.5m | $18.7m | $34.6m | $49.4m | $30.2m | $29.9m | |
| Impairment | — | — | — | — | $0 | $166.2m | $84.6m | — | |
| Accounts receivable | ($1.9m) | ($33.1m) | ($70.4m) | ($22.3m) | $84.4m | $14.4m | $12.8m | ($3.5m) | |
| Inventory | $106k | ($19.1m) | ($21.6m) | $9.5m | $649k | $377k | $8.0m | $3.7m | |
| Accounts payable | $2.5m | $1.2m | $676k | ($1.6m) | $5.3m | $723k | ($7.3m) | ($4.1m) | |
| Property and equipment included in accounts payable and accrued expenses | $2.8m | $2.0m | $2.1m | $1.7m | $2.0m | $2.6m | $3.7m | — | |
| Accrued expenses and other current liabilities | $3.5m | $17.8m | ($3.5m) | $8.5m | $15.1m | ($22.8m) | ($4.6m) | — | |
| Accrued receivable for capital expenditures to be reimbursed under a government contract | — | — | $0 | $0 | $1.1m | $734k | $0 | — | |
| Other | $688k | $2.4m | ($281k) | ($8.0m) | ($2.3m) | $833k | $212k | — | |
| Prepaid expenses and other current assets | ($2.0m) | ($5.5m) | ($9.5m) | ($52.9m) | $8.1m | $2.0m | $1.6m | — | |
| Other assets | — | — | — | — | $861k | $153k | $181k | — | |
| Net cash (used in) provided by operating activities | $24.1m |
$152.2m
+531.09%
|
$368.6m
+142.18%
|
$536.0m
+45.42%
|
$126.2m
-76.45%
|
$7.5m
-94.09%
|
($57.6m)
-871.24%
|
($25.3m)
+56.12%
|
|
| Purchases of property and equipment | ($17.1m) | ($25.4m) | ($14.8m) | ($17.1m) | ($65.6m) | ($29.7m) | ($13.1m) | ($10.6m) | |
| Proceeds from government assistance allocated to property and equipment | $15k | $0 | $0 | $1.1m | $12.9m | $7.1m | $734k | — | |
| Cash paid for acquisitions of a business, net of cash acquired | — | — | $0 | ($239.0m) | ($69.6m) | $0 | ($19.0m) | — | |
| Other investing activities, net | — | — | — | — | $0 | ($1.8m) | $0 | — | |
| Net cash used in investing activities | ($17.1m) | $6.1m | $105.7m | ($267.6m) | ($122.3m) | ($24.3m) | ($31.4m) | ($9.8m) | |
| Loss on extinguishment of debt | $0 | $7.6m | $0 | $208k | $0 | $3.2m | $0 | — | |
| Principal repayments of long-term debt | ($2.5m) | ($411.9m) | ($6.0m) | ($13.9m) | ($5.4m) | ($234.4m) | ($5.4m) | — | |
| Financing costs paid to acquire long-term debt | $0 | ($9.3m) | $0 | $0 | $0 | ($1.2m) | $0 | — | |
| Other financing activities, net | — | — | — | — | ($352k) | ($1.8m) | ($5.6m) | — | |
| Net cash used in financing activities | ($4.2m) |
$53.2m
+1376.99%
|
($159.0m)
-398.90%
|
($187.5m)
-17.89%
|
($61.1m)
+67.42%
|
($235.7m)
-285.84%
|
($16.5m)
+93.00%
|
($164.3m)
-895.64%
|
|
| Cash and cash equivalents, beginning of period | $24.7m | $236.2m | $551.3m | $632.1m | $575.0m | $322.4m | $216.9m | — | |
| Effects of exchange rate changes on cash | $34k | $17k | ($88k) | $0 | $0 | $0 | ($32k) | — | |
| Additional Supplementary Disclosures | |||||||||
| Additional Supplementary Disclosures | |||||||||
| Change in estimated fair value of contingent consideration | — | $0 | $0 | ($7.8m) | ($3.3m) | ($2.0m) | $0 | — | |
| Revaluation of liabilities under the Tax Receivable Agreement | $0 | $0 | ($6.1m) | $4.1m | ($668.9m) | $40k | $0 | — | |
| Acquisition related tax adjustment | — | — | — | $349k | $1.3m | $2.3m | $4.1m | — | |
| Other long-term liabilities | $0 | ($2.5m) | ($4.5m) | $3.8m | ($16.0m) | ($6.3m) | ($18.6m) | — | |
| Refunds (distributions) for tax liabilities to non-controlling interests holder | — | — | — | — | ($9.6m) | ($494k) | $10k | — | |
| Proceeds from interest rate cap agreement | — | — | $0 | $0 | $6.2m | $9.3m | $1.4m | — | |
| Payments of acquisition related contingent consideration and consideration holdback | ($1.3m) | ($1.4m) | $0 | $0 | ($9.7m) | $0 | ($6.8m) | — | |
| Payments pursuant to the Tax Receivable Agreement | $0 | $0 | ($1.3m) | ($34.2m) | ($42.2m) | ($7.1m) | $0 | — | |
| Net decrease in cash and cash equivalents | $2.8m | $211.5m | $315.1m | $80.9m | ($57.2m) | ($252.6m) | ($105.5m) | — | |
| Cash paid for interest | $28.7m | $28.9m | $27.2m | $20.2m | $44.3m | $51.0m | $25.0m | — | |
| Cash (refunded) paid for income taxes, net | $802k | $5.0m | $22.5m | $23.0m | ($3.0m) | $670k | ($555k) | — | |
| Right-of-use assets obtained in exchange for finance lease liabilities | — | — | $0 | $0 | $32.9m | $0 | $0 | — | |
| Right-of-use assets obtained in exchange for operating lease liabilities | — | $0 | $0 | $17.5m | $3.9m | $1.3m | $463k | — | |
| Fair value of contingent consideration liability recorded in connection with acquisition of a business | — | $0 | $0 | ($7.8m) | $5.3m | $0 | $0 | — |